ENDPOINTS NEWS38m
Hand­ful of 'un­sup­port­ed' drug price in­creas­es added $800M to US costs, ICER claims
ICER reports $800M+ annual US cost increase from 5 drugs (Biktarvy, Darzalex, Entresto, Cabometyx, Xeljanz) with 2023 price ...
Unsupported price hikes added $815 million to US drug spending in 2023
Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not ...
Managed Healthcare Executive2h
ICER Identifies 5 Drugs with Unsupported Price Increases
The Institute for Clinical and Economic Review has identified five drugs — Biktarvy, Darzalex, Entresto, Cabometyx, and ...